Seagen Inc - Company Profile
Powered by 
All the sales intelligence you need on Seagen Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Seagen Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Seagen Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Seagen Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390290A1 | Application | Treatment of her2 positive cancers | A61K31/517; A61K31/7068; A61K39/39558; A61P35/00 | December 07, 2023 |
| US20230391848A1 | Application | Selective reduction of proteins | A61K47/68; A61K47/6817; A61K47/6889; C07K1/086; C07K1/1133; C07K1/36; C07K16/00; C07K2317/52; C07K2317/53 | December 07, 2023 |
| WO2023230429A1 | Application | Methods of treating colorectal cancer with tucatinib in combination with an anti-her2 antibody | A61K39/395; A61P35/00; C07K16/32 | November 30, 2023 |
| ZA201907225B | Grant | Treatment of her2 positive cancers | A61K2039/505; A61K2039/542; A61K2039/545; A61K2300/00; A61K31/517; A61K31/7068; A61K39/39558; A61K45/06; A61P35/00; A61P35/04; C07K16/32 | November 29, 2023 |
| US11827709B2 | Grant | Anti-avb6 antibodies and antibody-drug conjugates | A61K38/07; A61K45/06; A61K47/545; A61K47/65; A61K47/6803; A61K47/6849; A61P35/00; C07K16/2839; C07K2317/24 | November 28, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer